These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38910744)

  • 41. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score.
    Addad VV; Palma LMP; Vaisbich MH; Pacheco Barbosa AM; da Rocha NC; de Almeida Cardoso MM; de Almeida JTC; de Paula de Sordi MA; Machado-Rugolo J; Arantes LF; de Andrade LGM
    Thromb J; 2023 Nov; 21(1):119. PubMed ID: 37993892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy].
    Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y
    Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.
    Shen YM
    Thromb J; 2016; 14(Suppl 1):19. PubMed ID: 27766045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.
    Trojnar E; Józsi M; Szabó Z; Réti M; Farkas P; Kelen K; Reusz GS; Szabó AJ; Garam N; Mikes B; Sinkovits G; Mező B; Csuka D; Prohászka Z
    Front Immunol; 2019; 10():240. PubMed ID: 30858847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study.
    Henry N; Mellaza C; Fage N; Beloncle F; Genevieve F; Legendre G; Orvain C; Garnier AS; Cousin M; Besson V; Subra JF; Duveau A; Augusto JF; Brilland B
    Front Med (Lausanne); 2021; 8():566678. PubMed ID: 33718396
    [No Abstract]   [Full Text] [Related]  

  • 47. Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease.
    Nitzan-Luques A; Slae M; Zugayar D; Dixon BP; Meir K; Volovelsky O
    J Nephrol; 2021 Feb; 34(1):241-245. PubMed ID: 32514992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.
    Malgaj Vrečko M; Aleš Rigler A; Večerić-Haler Ž
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombotic microangiopathy in cancer.
    Weitz IC
    Thromb Res; 2018 Apr; 164 Suppl 1():S103-S105. PubMed ID: 29703465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy.
    Nishi K; Sato M; Ogura M; Okutsu M; Ishikura K; Kamei K
    BMC Nephrol; 2020 Aug; 21(1):323. PubMed ID: 32746791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
    Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
    J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.
    Masuda E; Fukushima K; Hebisawa Y; Tanaka M; Ohta A; Imamura A
    Medicine (Baltimore); 2023 Oct; 102(41):e35469. PubMed ID: 37832064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic dilemma in postpartum associated hemolytic uremic syndrome in a 38th week pregnant 31-year-old Congolese: a case report.
    Tshilanda M; Kanmounye US; Tendobi C; Mbuyi F
    BMC Pregnancy Childbirth; 2020 Aug; 20(1):495. PubMed ID: 32854648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diclofenac-induced thrombotic thrombocytopenic purpura with concomitant complement dysregulation: a case report and review of the literature.
    Lara JP; Santana Y; Gaddam M; Ali A; Malik S; Khaja M
    J Med Case Rep; 2019 Jun; 13(1):190. PubMed ID: 31228952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical hemolytic-uremic syndrome due to complement factor I mutation.
    Almalki AH; Sadagah LF; Qureshi M; Maghrabi H; Algain A; Alsaeed A
    World J Nephrol; 2017 Nov; 6(6):243-250. PubMed ID: 29226095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations.
    Hossain MA; Cheema A; Kalathil S; Bajwa R; Costanzo EJ; Cosentino J; Cheng J; Vachharajani T; Asif A
    Saudi J Kidney Dis Transpl; 2018; 29(2):276-283. PubMed ID: 29657193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ; Moliterno AR
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnosis and treatment of microangiopathic hemolytic anemia].
    Morishita E
    Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adult-onset Still's disease with concurrent thrombotic microangiopathy: Observations from pooled analysis for an uncommon finding.
    Ananthaneni A; Shimkus G; Weis F; Adu-Dapaah E; Lakra R; Ramadas P; Hayat S
    Eur J Haematol; 2024 Apr; 112(4):484-492. PubMed ID: 37997494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.